Cubist Systematic Strategies, LLC Celularity Inc Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.22 - $0.56 $9,224 - $23,480	-41,930 Reduced 40.18%	62,413 $13,000
Q2 2023 Aug 14, 2023	BUY	$0.42 - $0.81 $43,824 - $84,517	104,343 New	104,343 $55,000
Q4 2022 Feb 14, 2023	SELL	$1.08 - $2.35 $20,618 - $44,863	-19,091 Reduced 69.65%	8,318 $10,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $5,716 - $57,297	13,294 Added 94.18%	27,409 $63,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $39,663 - $182,224	14,115 New	14,115 $48,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.